207
Views
26
CrossRef citations to date
0
Altmetric
Original Research

Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma

, , , , , & show all
Pages 5465-5474 | Published online: 16 Oct 2012

References

  • El-SeragHBRudolphLHepatocellular carcinoma: epidemiology and molecular carcinogenesisGastroenterology20071322557257617570226
  • GabizonADaganAGorenDBarenholzYFuksZLiposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in miceCancer Res198242473447397127308
  • SafraTMuggiaFJeffersSPegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2Ann Oncol2000111029103311038041
  • YanXScherphofGLKampsJALiposome opsonizationJ Liposome Res20051510913916194930
  • HashidaMNishikawaMTakakuraYHepatic targeting of drugs and proteins by chemical modificationJ Control Release19953699107
  • RensenPCSliedregtLAFernsMDetermination of the upper size limit for uptake and processing of ligands by the asialoglycoprotein receptor on hepatocytes in vitro and in vivoJ Biol Chem2001276375773758411479285
  • SeymourLWFerryDRAndersonDHepatic drug targeting: phase 1 evaluation of polymer-bound doxorubicinJ Clin Oncol2002201668167611896118
  • WuJNantzMHZernMATargeting hepatocytes for drug and gene delivery: emerging novel approaches and applicationsFront Biosci20027717725
  • SuoAQianJYaoYZhangWGalactosylated poly(ethylene glycol)-b-poly (L-lactide-co-β-malic acid) block copolymer micelles for targeted drug delivery: preparation and in vitro characterizationInt J Nanomedicine201051029103821170351
  • ManagitCKawakamiSYamashitaFHashidaMEffect of galaclactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomesJ Pharm Sci2005942266227516136555
  • HattoriYKawakamiSYamashitaFHashidaMControlled biodistribution of galactosylated liposomes and incorporated probucol in hepatocyte-selective drug targetingJ Control Release20006936937711102677
  • ManagitCKawakamiSYamashitaFHashidaMUptake characteristics of galactosylated emulsion by HepG2 hepatoma cellsInt J Pharm200530125526116076536
  • WangSXuHXuJSynthesis of a novel galactosylated lipid and its application to the hepatocyte-selective targeting of liposomal doxorubicinEur J Pharm Biopharm200662323816226883
  • TeradaTIwaiMKawakamiSYamashitaFHashidaMNovel PEG-matrix metalloproteinase-2 cleavable peptide-lipid containing galactosylated liposomes for hepatocellular carcinoma-selective targetingJ Control Release200611133334216488046
  • XuZChenLGuWThe performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinomaBiomaterials20093022623218851881
  • SzokaFOlsonFHeathTVailWMayhewEPapahadjopoulosDReparation of unilamellar liposomes of intermediate size (0.1–0.2 μM) by a combination of reverse phase evaporation and extrusion through polycarbonate membranesBiochim Biophys Acta19806015595716251878
  • PanXQWangHLeeRJAntitumor activity of folate receptor-targeted liposomal doxorubicin in a KB oral carcinoma murine xenograft modelPharm Res20032041742212669962
  • LeeRJLowPSFolate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitroBiochim Biophys Acta199512331341447865538
  • LiHLuYPiaoLTargeting human clonogenic acute myelogenous leukemia cells via folate conjugated liposomes combined with receptor modulation by all-trans retinoic acidInt J Pharm2010402576320883757
  • MarksDCBelovLDaveyMWDaveyRAKidmanADThe MTT cell viability assay for cytotoxicity testing in multidrug-resistant human leukemic cellsLeuk Res199216116511731361210
  • XuSLiuYTaiHCZhuJDingHLeeRJSynthesis of transferrin (Tf) conjugated liposomes via Staudinger ligationInt J Pharm201140420521021056642
  • HongRLHuangCJTsengYLDirect comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial?Clin Cancer Res199953645365210589782
  • TagamiTErnstingMJLiSDEfficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicinJ Control Release201115230330921338635
  • LaginhaKMVerwoertSCharroisGJAllenTMDetermination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumorsClinCancer Res20051169446949
  • HanHDLeeAHwangTEnhanced circulation time and antitumor activity of doxorubicin by comblike polymer-incorporated liposomesJ Control Release200712016116817524514
  • WangSDengYXuHWuHQiuYChenDSynthesis of a novel galactosylated lipid and its application to the hepatocyte-selective targeting of liposomal doxorubicinEur J Pharm Biopharm200662323816226883
  • AllenTMLong-circulating (sterically stabilized) liposomes for targeted drug deliveryTrends Pharmacol Sci1994152152207940982
  • GabizonAPapahadjopoulosDLiposome formulations with prolonged circulation time in blood and enhanced uptake by tumorsProc Natl Acad Sci U S A198885694969533413128
  • WoodleMCLasicDDSterically stabilized liposomesBiochim Biophys Acta199211131711991510996
  • MayerLDTaiLCKoDSInfluence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in miceCancer Res198949592259302790807
  • GabizonAASelective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomesCancer Res1992528918961737351
  • JainNKJainSKDevelopment and in vitro characterization of galactosylated low molecular weight chitosan nanoparticles bearing doxorubicinAAPS PharmSciTech20101168669720414758
  • BernardesGJKikkeriRMaglinaoMDesign, synthesis and biological evaluation of carbohydrate-functionalized cyclodextrins and the liposomes for hepatocyte-specific targetingOrg Biomol Chem201084987499620820666
  • KikkeriRLepeniesBAdibekianALauorinoPSeebergerPHIn vitro imaging and in vivo liver targeting with carbohydrate capped quantum dotsJ Am Chem Soc20091312110211219199612
  • HiguchiYOkaMKawakamiSHashidaMMannosylated semiconductor quantum dots for the labeling of macrophagesJ Control Release200812513113618045722
  • LongmuirKJHaynesSMBarattaJLKasabwallaNRobertsonRTLiposomal delivery of doxorubicin to hepatocytes in vivo by targeting heparin sulfateInt J Pharm200938222223319664697
  • GewirtzDAA critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicinBiochem Pharmacol19995772774110075079